Bengaluru, August 1:
PlasmaGen BioSciences Pvt Ltd, a city-based bio-pharmaceutical company focused on blood plasma-derived products, on Tuesday announced $25-million investment from Eight Roads Ventures and F-Prime Capital.
The terms of the transaction were not disclosed.
This is the first round of external funding for the company, PlasmaGen said in a release.
(This article was published on August 1, 2017)
Get more of your favourite news delivered to your inbox
Please enter your email. Thank You.
Newsletter has been successfully subscribed.